technetium-tc-99m-exametazime and Pantothenate-Kinase-Associated-Neurodegeneration

technetium-tc-99m-exametazime has been researched along with Pantothenate-Kinase-Associated-Neurodegeneration* in 1 studies

Other Studies

1 other study(ies) available for technetium-tc-99m-exametazime and Pantothenate-Kinase-Associated-Neurodegeneration

ArticleYear
[Hallervorden-Spatz syndrome. Differential diagnosis of early onset dementia].
    Der Nervenarzt, 1999, Volume: 70, Issue:5

    We report the history of a 38 year old patient who began to develop mental deterioration at the age of 26. After a time of 7 years neurological signs like writing dystonia occurred. Hallervorden-Spatz-Disease (HSD) was diagnosed at the age of 36 in vivo with the clinical presentation of severe dystonia, rigidity, dementia, and typical signal loss in the globus-pallidus the reticular part of the substantia nigra, and the nucleus ruber in the T-2 weighted MRI. The "eye-of-the-tiger"-sign, a bilateral hyperintensity in the rostral globus pallidus, was not observed in follow-up examinations. HSD is a rare autosomal-recessive or sporadic disease of unknown etiology. In one third of the patients a dementing process is the first clinical sign of the disorder, and is a rare differential diagnosis of early onset dementia.

    Topics: Adult; Atrophy; Brain; Cognition Disorders; Dementia; Diagnosis, Differential; Disease Progression; Dystonia; Globus Pallidus; Humans; Magnetic Resonance Imaging; Male; Pantothenate Kinase-Associated Neurodegeneration; Red Nucleus; Substantia Nigra; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon

1999